Peptide therapy TikTok claims: what the science actually supports

What did @samantha.stephens21 actually say?

The creator walked through dosing logic for MOTS-c, a mitochondria-derived peptide. Her core argument: because MOTS-c works by "stressing the mitochondria," daily dosing is dangerous, and users should dose three times per week based on bodyweight. She suggested 15-20 mg per week for a ~160-170 lb adult, split into three doses, and said she personally takes 2 mg three times weekly at 107 lbs. She also acknowledged upfront that "there is very minimal human research" and most evidence comes from animal studies.

That transparency matters and it's worth crediting. But acknowledgment of limited evidence does not neutralize specific dosing numbers presented as authoritative recommendations, which is exactly what happens in this video. The numbers she gives sound precise. They aren't grounded in clinical trials.

Does the science back this up?

Partially, on mechanism. Not at all on the specific doses. MOTS-c is a real peptide encoded in mitochondrial DNA, and AMPK activation is genuinely part of its studied mechanism. But human dosing data is nearly nonexistent.

Lee et al. (2015, Cell Metabolism) identified MOTS-c as a mitochondrial-derived peptide that activates AMPK and improves insulin sensitivity in mice. That foundational work is solid. More recently, Kim et al. (2021, Nature Communications) showed MOTS-c improves physical performance and metabolism in aged mice. A 2022 pilot in older adults (Reynolds et al., Nature Aging) tested 2 mg/kg subcutaneous injections and found metabolic benefits, but this was a small, early-phase study. The 15-20 mg per week figure the creator cites does not appear in any published human trial. It likely originates from biohacker forums and compounding pharmacy protocols, which are not the same thing as clinical evidence.

What did they get wrong (or right)?

The mechanism explanation is directionally correct but oversimplified. Saying MOTS-c "stresses the mitochondria" to produce benefits is a rough approximation of hormesis, which is a real concept. The concern about overdoing it also has some biological logic, though the claim that too-frequent dosing causes "heart issues" is not something the current literature supports with specificity.

Where it goes wrong is the bodyweight-based dosing math. The creator implies a linear relationship between bodyweight and dose, presenting her own 2 mg x3/week as derived from her 107-lb frame. There is no published pharmacokinetic model in humans that validates this approach. The 15-20 mg weekly figure for a 160-lb adult is also significantly higher than what the only published human pilot used. Presenting forum-derived numbers with the same confidence as study-derived numbers is misleading, even when a disclaimer is attached at the end.

What should you actually know?

MOTS-c is one of the more interesting peptides in longevity research right now, but it is genuinely early-stage. Here is what the evidence actually supports:

• MOTS-c activates AMPK signaling and has shown metabolic and physical performance benefits in animal models (Lee et al., 2015; Kim et al., 2021).
• The only human trial to date is small and used weight-based dosing of 2 mg/kg, not a flat weekly total adjusted by size.
• There is no published human data establishing that 15-20 mg per week is safe or effective for any adult, regardless of bodyweight.
• The idea that you can calculate your personal dose from bodyweight based on a TikTok video is not how peptide pharmacology works in a clinical setting.
• If you are considering MOTS-c, this conversation belongs with a licensed provider who can review your metabolic panel and health history, not a comment thread or a social video.

The creator means well. The disclaimer at the end is genuine. But good intentions do not make unvalidated dosing numbers safer.